Boosted Survival of Ventilated COVID-19 Patients by 200 Percent
Posted by Bluangel on June 9, 2021, 11:21 am
A new study has found that the use of weight-adjusted Hydroxychloroquine (HCQ) and Azithromycin (AZM) improved the survival of ventilated COVID-19 patients by nearly 200 percent.